Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

Source:http://linkedlifedata.com/resource/pubmed/id/18373192

Download in:

View as

General Info

PMID
18373192